Rui M Rua1, M Luisa Ojeda1, Fátima Nogales1, Jose Maria Rubio2, Manuel Romero-Gómez3, Jorge Funuyet3, M Luisa Murillo1, Olimpia Carreras4. 1. Department of Physiology, Faculty of Pharmacy, Seville University, Seville, Spain. 2. Department of Medicine, Faculty of Medicine, Seville University, Seville, Spain. 3. Unit for the Clinical Management of Digestive Diseases and CIBEREHD, University Hospital of Valme, Seville, Spain. 4. Department of Physiology, Faculty of Pharmacy, Seville University, Seville, Spain. Electronic address: olimpia@us.es.
Abstract
AIMS: Antioxidant system abnormalities have been associated with ethanol consumption. This study examines the effects of chronic ethanol consumption on oxidative balance, including selenium (Se) levels in alcoholic patients with or without liver disease, and if these measurements could be indicative of liver disease. MAIN METHODS: Serum Se levels, antioxidant enzymes' activities, malondialdehyde (MDA) and protein carbonyl (PC) were determined in three groups of patients: alcoholics without liver disease, alcoholics with liver disease, and non-alcoholics with liver disease; and in healthy volunteers. KEY FINDINGS: Serum Se levels were lower in alcoholic patients and in patients affected by liver disease and especially lower in the alcoholic liver disease group. These values were correlated with the activity of glutathione peroxidase (GPx), the antioxidant selenoprotein. The antioxidant activities of the glutathione reductase (GR) and superoxide dismutase (SOD) were also lower in the three non-healthy groups. However, GR activity decreased and SOD activity increased in the non-alcoholic liver disease group versus alcoholic groups. Higher concentrations of PC in serum were found in non-healthy groups and were higher in alcoholic patients who also showed higher MDA levels. The highest MDA and PC levels were found in the alcoholic liver disease group. SIGNIFICANCE: We conclude that serum Se levels are drastically decreased in alcoholic liver disease patients, showing that this element has a direct correlation with GPx activity, and lipid oxidation, suggesting that the serum Se/MDA ratio could be an indicator of hepatic damage caused by alcohol consumption, and pointing to Se as a possible antioxidant therapy.
AIMS: Antioxidant system abnormalities have been associated with ethanol consumption. This study examines the effects of chronic ethanol consumption on oxidative balance, including selenium (Se) levels in alcoholicpatients with or without liver disease, and if these measurements could be indicative of liver disease. MAIN METHODS: Serum Se levels, antioxidant enzymes' activities, malondialdehyde (MDA) and protein carbonyl (PC) were determined in three groups of patients: alcoholics without liver disease, alcoholics with liver disease, and non-alcoholics with liver disease; and in healthy volunteers. KEY FINDINGS: Serum Se levels were lower in alcoholicpatients and in patients affected by liver disease and especially lower in the alcoholic liver disease group. These values were correlated with the activity of glutathione peroxidase (GPx), the antioxidant selenoprotein. The antioxidant activities of the glutathione reductase (GR) and superoxide dismutase (SOD) were also lower in the three non-healthy groups. However, GR activity decreased and SOD activity increased in the non-alcoholic liver disease group versus alcoholic groups. Higher concentrations of PC in serum were found in non-healthy groups and were higher in alcoholicpatients who also showed higher MDA levels. The highest MDA and PC levels were found in the alcoholic liver disease group. SIGNIFICANCE: We conclude that serum Se levels are drastically decreased in alcoholic liver diseasepatients, showing that this element has a direct correlation with GPx activity, and lipid oxidation, suggesting that the serum Se/MDA ratio could be an indicator of hepatic damage caused by alcohol consumption, and pointing to Se as a possible antioxidant therapy.
Authors: Marina Galicia-Moreno; Dorothy Rosique-Oramas; Zaira Medina-Avila; Tania Álvarez-Torres; Dalia Falcón; Fátima Higuera-de la Tijera; Yadira L Béjar; Paula Cordero-Pérez; Linda Muñoz-Espinosa; José Luis Pérez-Hernández; David Kershenobich; Gabriela Gutierrez-Reyes Journal: Oxid Med Cell Longev Date: 2016-12-15 Impact factor: 6.543
Authors: Jacek Baj; Wojciech Flieger; Grzegorz Teresiński; Grzegorz Buszewicz; Ryszard Sitarz; Alicja Forma; Kaja Karakuła; Ryszard Maciejewski Journal: J Clin Med Date: 2020-06-18 Impact factor: 4.241
Authors: Andrzej Prystupa; Paweł Kiciński; Dorota Luchowska-Kocot; Anna Błażewicz; Jarosław Niedziałek; Grzegorz Mizerski; Mariusz Jojczuk; Andrzej Ochal; Jarosław J Sak; Wojciech Załuska Journal: Int J Environ Res Public Health Date: 2017-04-21 Impact factor: 3.390